Suchergebnisse - "Touzeau, Cyrille"

PubPharm (102)

51

Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients : a prospective multicenter study

enthalten in: Haematologica | 2016

von Garderet, L. | Beohou, E. | Caillot, D. | +13

52

The REFRACT-LYMA cohort study : a French observational prospective cohort study of patients with mantle cell lymphoma

enthalten in: BMC cancer | 2016

von Hanf, M. | Chiron, D. | de Visme, S. | +6

53

The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma

enthalten in: BMC cancer | 2016

von Hanf, M. | Chiron, D. | de Visme, S. | +6

54

The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma

enthalten in: BMC cancer | 2016

von Hanf, M. | Chiron, D. | de Visme, S. | +6

55

Predictors of survival in patients with surgical spine multiple myeloma metastases

enthalten in: Surgical oncology | 2016

von Amelot, A. | Moles, A. | Cristini, J. | +5

56

Pomalidomide in the management of relapsed multiple myeloma

enthalten in: Future oncology (London, England) | 2016

von Touzeau, C. | Moreau, P.

57

Quisinostat, bortezomib, and dexamethasone combination therapy for relapsed multiple myeloma

enthalten in: Leukemia & lymphoma | 2016

von Moreau, P. | Facon, T. | Touzeau, C. | +10

58

Similarity of fractionated versus single dose(s) of gemtuzumab ozogamicin as part of the MIDAM salvage regimen in relapsed/refractory acute myeloid leukemia patients

enthalten in: Seminars in hematology | 2016

von Peterlin, P. | Guillaume, T. | Delaunay, J. | +13

59

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

enthalten in: The New England journal of medicine | 2016

von Moreau, P. | Masszi, T. | Grzasko, N. | +124

CommentIn: Nat Rev Clin Oncol. 2016 Jul;13(7):398. - PMID 27217276

60

How I treat extramedullary myeloma

enthalten in: Blood | 2016

von Touzeau, C. | Moreau, P.